🇺🇸 FDA
Patent

US 9718835

20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent

granted A61PA61P35/00

Quick answer

US patent 9718835 (20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent) held by China Medical University Hospital expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University Hospital
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P35/00